Supplementary Figure 4 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391604

2023-01-01

Abstract:PDF file - 34K, Reduction of ssDNA by inhibition of Mre11

What problem does this paper attempt to address?

Supplementary Figure 5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391601

2023-01-01

Abstract:PDF file - 79K, Stalled replication forks are protected from degradation in PARP inhibitor-resistant cells
Supplementary Figure 2 from Mre11-Dependent Degradation of Stalled DNA Replication Forks is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391610.v1

2023-01-01

Abstract:PDF file - 34K, Mre11 foci formation in BRCA2 deficient cells is independent of NHEJ
Supplementary Figure Legends 1-5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391598

2023-01-01

Abstract:PDF file - 24K
Supplementary Figure Legends from DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair

Songmin Ying,Zhihui Chen,Annette L. Medhurst,Jessica A. Neal,Zhengqiang Bao,Oliver Mortusewicz,Joanna F. McGouran,Xiaomin Song,Huahao Shen,Freddie C. Hamdy,Benedikt M. Kessler,Katheryn Meek,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22411764.v1

2023-01-01

Abstract:Supplementary Figure Legends
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells

Emily Cybulla,Sierra Wallace,Alice Meroni,Jessica Jackson,Sumedha Agashe,Mithila Tennakoon,Mangsi Limbu,Annabel Quinet,Elena Lomonosova,Hollie Noia,Stephanie Tirman,Matthew Wood,Delphine Lemacon,Katherine Fuh,Lee Zou,Alessandro Vindigni

DOI: https://doi.org/10.1093/nar/gkae563

2024-08-27

Abstract:BRCA1/2 proteins function in genome stability by promoting repair of double-stranded DNA breaks through homologous recombination and by protecting stalled replication forks from nucleolytic degradation. In BRCA1/2-deficient cancer cells, extensively degraded replication forks can be rescued through distinct fork recovery mechanisms that also promote cell survival. Here, we identified a novel pathway mediated by the E3 ubiquitin ligase RAD18, the E2-conjugating enzyme UBC13, the recombination factor PALB2, the E3 ubiquitin ligase RNF168 and PCNA ubiquitination that promotes fork recovery in BRCA1- but not BRCA2-deficient cells. We show that this pathway does not promote fork recovery by preventing replication fork reversal and degradation in BRCA1-deficient cells. We propose a mechanism whereby the RAD18-UBC13-PALB2-RNF168 axis facilitates resumption of DNA synthesis by promoting re-annealing of the complementary single-stranded template strands of the extensively degraded forks, thereby allowing re-establishment of a functional replication fork. We also provide preliminary evidence for the potential clinical relevance of this novel fork recovery pathway in BRCA1-mutated cancers, as RAD18 is over-expressed in BRCA1-deficient cancers, and RAD18 loss compromises cell viability in BRCA1-deficient cancer cells.
BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage

Zhihua Kang,Pan Fu,Allen L. Alcivar,Haiqing Fu,Christophe Redon,Tzeh Keong Foo,Yamei Zuo,Caiyong Ye,Ryan Baxley,Advaitha Madireddy,Remi Buisson,Anja-Katrin Bielinsky,Lee Zou,Zhiyuan Shen,Mirit I. Aladjem,Bing Xia

DOI: https://doi.org/10.1038/s41467-021-26227-6

IF: 16.6

2021-01-01

Nature Communications

Abstract:The BRCA2 tumor suppressor protects genome integrity by promoting homologous recombination-based repair of DNA breaks, stability of stalled DNA replication forks and DNA damage-induced cell cycle checkpoints. BRCA2 deficient cells display the radio-resistant DNA synthesis (RDS) phenotype, however the mechanism has remained elusive. Here we show that cells without BRCA2 are unable to sufficiently restrain DNA replication fork progression after DNA damage, and the underrestrained fork progression is due primarily to Primase-Polymerase (PRIMPOL)-mediated repriming of DNA synthesis downstream of lesions, leaving behind single-stranded DNA gaps. Moreover, we find that BRCA2 associates with the essential DNA replication factor MCM10 and this association suppresses PRIMPOL-mediated repriming and ssDNA gap formation, while having no impact on the stability of stalled replication forks. Our findings establish an important function for BRCA2, provide insights into replication fork control during the DNA damage response, and may have implications in tumor suppression and therapy response.
UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells

Tian Tian,Junliang Chen,Huacun Zhao,Yulin Li,Feiyu Xia,Jun Huang,Jinhua Han,Ting Liu

DOI: https://doi.org/10.1038/s41589-024-01611-7

IF: 14.8

2024-04-23

Nature Chemical Biology

Abstract:The stabilization of stalled forks has emerged as a crucial mechanism driving resistance to poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2-deficient tumors. Here, we identify UFL1, a UFM1-specific E3 ligase, as a pivotal regulator of fork stability and the response to PARP inhibitors in BRCA1/2-deficient cells. On replication stress, UFL1 localizes to stalled forks and catalyzes the UFMylation of PTIP, a component of the MLL3/4 methyltransferase complex, specifically at lysine 148. This modification facilitates the assembly of the PTIP–MLL3/4 complex, resulting in the enrichment of H3K4me1 and H3K4me3 at stalled forks and subsequent recruitment of the MRE11 nuclease. Consequently, loss of UFL1, disruption of PTIP UFMylation or overexpression of the UFM1 protease UFSP2 protects nascent DNA strands from extensive degradation and confers resistance to PARP inhibitors in BRCA1/2-deficient cells. These findings provide mechanistic insights into the processes underlying fork instability in BRCA1/2-deficient cells and offer potential therapeutic avenues for the treatment of BRCA1/2-deficient tumors.

biochemistry & molecular biology
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

Yiduo Hu,Sarah A Petit,Scott B Ficarro,Kimberly J Toomire,Anyong Xie,Elgene Lim,Shiliang A Cao,Eunyoung Park,Michael J Eck,Ralph Scully,Myles Brown,Jarrod A Marto,David M Livingston

DOI: https://doi.org/10.1158/2159-8290.CD-13-0891

IF: 28.2

2014-01-01

Cancer Discovery

Abstract:BRCA1 promotes homologous recombination-mediated DNA repair (HRR). However, HRR must be tightly regulated to prevent illegitimate recombination. We previously found that BRCA1 HRR function is regulated by the RAP80 complex, but the mechanism was unclear. We have now observed that PARP1 interacts with and poly-ADP-ribosylates (aka PARsylates) BRCA1. PARsylation is directed at the BRCA1 DNA binding domain and downmodulates its function. Moreover, RAP80 contains a poly-ADP-ribose-interacting domain that binds PARsylated BRCA1 and helps to maintain the stability of PARP1-BRCA1-RAP80 complexes. BRCA1 PARsylation is a key step in BRCA1 HRR control. When BRCA1 PARsylation is defective, it gives rise to excessive HRR and manifestations of genome instability. BRCA1 PARsylation and/or RAP80 expression is defective in a subset of sporadic breast cancer cell lines and patient-derived tumor xenograft models. These observations are consistent with the possibility that such defects, when chronic, contribute to tumor development in BRCA1(+/+) individuals. SIGNIFICANCE: We propose a model that describes how BRCA1 functions to both support and restrict HRR. BRCA1 PARsylation is a key event in this process, failure of which triggers hyper-recombination and chromosome instability. Thus, hyperfunctioning BRCA1 can elicit genomic abnormalities similar to those observed in the absence of certain BRCA1 functions. (C) 2014 AACR.
DNA replication fork stabilization and restart mechanisms revealed by biochemical reconstitution

Berta Canal,Agostina P. Bertolin,Giselle C. Lee,Masashi Minamino,John F.X. Diffley

DOI: https://doi.org/10.1101/2024.11.01.621508

2024-11-03

Abstract:Understanding how DNA replication forks stall and restart and how the DNA damage checkpoint prevents irreversible fork collapse in molecular detail are crucial for understanding how cells maintain stable genomes and how they prevent the genetic instability that drives cancer. Here we describe the reconstitution of fork stalling and restart with purified budding yeast proteins. After nucleotide depletion, leading strand DNA synthesis quickly stops but CMG helicase continues to unwind and Okazaki fragments continue to initiate on the lagging strand. Incomplete Okazaki fragments sequester PCNA, RFC and DNA polymerases δ and ε which prevents normal DNA synthesis restart and exposes nascent DNA to nuclease attack. The DNA damage checkpoint limits this sequestration by restraining fork progression, which protects stalled forks from collapse and ensures restart.

Biochemistry
The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

Thomas Helleday

DOI: https://doi.org/10.1016/j.molonc.2011.07.001

2011-07-22

Molecular Oncology

Abstract:Poly (ADP‐ribose) polymerase (PARP) inhibitors effectively kill tumours defective in the BRCA1 or BRCA2 genes through the concept of synthetic lethality. It is suggested that PARP inhibitors cause an increase in DNA single‐strand breaks (SSBs), which are converted during replication to irreparable toxic DNA double‐strand breaks (DSBs) in BRCA1/2 defective cells. There are a number of recent reports challenging this model. Here, alternative models that are not mutually exclusive are presented to explain the synthetic lethality between BRCA1/2 and PARP inhibitors. One such model proposes that PARP inhibition causes PARP‐1 to be trapped onto DNA repair intermediates, especially during base excision repair. This may in turn cause obstruction to replication forks, which require BRCA‐dependent homologous recombination to be resolved. In another model, PARP is directly involved in catalysing replication repair in a distinct pathway from homologous recombination. Experimental evidence supporting these novel models to explain the PARP‐BRCA synthetic lethality are discussed.

oncology
Replication fork stalling in late S-phase elicits nascent strand degradation by DNA mismatch repair

Erica Colicino-Murbach,Caitlin Hathaway,Huzefa Dungrawala

DOI: https://doi.org/10.1093/nar/gkae721

IF: 14.9

2024-08-27

Nucleic Acids Research

Abstract:Eukaryotic chromosomal replication occurs in a segmented, temporal manner wherein open euchromatin and compact heterochromatin replicate during early and late S-phase respectively. Using single molecule DNA fiber analyses coupled with cell synchronization, we find that newly synthesized strands remain stable at perturbed forks in early S-phase. Unexpectedly, stalled forks are susceptible to nucleolytic digestion during late replication resulting in defective fork restart. This inherent vulnerability to nascent strand degradation is dependent on fork reversal enzymes and resection nucleases MRE11, DNA2 and EXO1. Inducing chromatin compaction elicits digestion of nascent DNA in response to fork stalling due to reduced association of RAD51 with nascent DNA. Furthermore, RAD51 occupancy at stalled forks in late S-phase is diminished indicating that densely packed chromatin limits RAD51 accessibility to mediate replication fork protection. Genetic analyses reveal that susceptibility of late replicating forks to nascent DNA digestion is dependent on EXO1 via DNA mismatch repair (MMR) and that the BRCA2-mediated replication fork protection blocks MMR from degrading nascent DNA. Overall, our findings illustrate differential regulation of fork protection between early and late replication and demonstrate nascent strand degradation as a critical determinant of heterochromatin instability in response to replication stress.

biochemistry & molecular biology
C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption

Abhishek Bharadwaj Sharma,Muhammad Khairul Ramlee,Joel Kosmin,Martin R Higgs,Amy Wolstenholme,George E Ronson,Dylan Jones,Daniel Ebner,Noor Shamkhi,David Sims,Paul W G Wijnhoven,Josep V Forment,Ian Gibbs-Seymour,Nicholas D Lakin

DOI: https://doi.org/10.1038/s41467-023-40779-9

2023-08-17

Abstract:While the toxicity of PARP inhibitors to cells with defects in homologous recombination (HR) is well established, other synthetic lethal interactions with PARP1/PARP2 disruption are poorly defined. To inform on these mechanisms we conducted a genome-wide screen for genes that are synthetic lethal with PARP1/2 gene disruption and identified C16orf72/HAPSTR1/TAPR1 as a novel modulator of replication-associated R-loops. C16orf72 is critical to facilitate replication fork restart, suppress DNA damage and maintain genome stability in response to replication stress. Importantly, C16orf72 and PARP1/2 function in parallel pathways to suppress DNA:RNA hybrids that accumulate at stalled replication forks. Mechanistically, this is achieved through an interaction of C16orf72 with BRCA1 and the RNA/DNA helicase Senataxin to facilitate their recruitment to RNA:DNA hybrids and confer resistance to PARP inhibitors. Together, this identifies a C16orf72/Senataxin/BRCA1-dependent pathway to suppress replication-associated R-loop accumulation, maintain genome stability and confer resistance to PARP inhibitors.
Ubiquitinated-PCNA protects replication forks from DNA2-mediated degradation by regulating Okazaki fragment maturation and chromatin assembly

Tanay Thakar,Wendy Leung,Claudia M. Nicolae,Kristen E. Clements,Binghui Shen,Anja-Katrin Bielinsky,George-Lucian Moldovan

DOI: https://doi.org/10.1038/s41467-020-16096-w

IF: 16.6

2020-05-01

Nature Communications

Abstract:Abstract Upon genotoxic stress, PCNA ubiquitination allows for replication of damaged DNA by recruiting lesion-bypass DNA polymerases. However, PCNA is also ubiquitinated during normal S-phase progression. By employing 293T and RPE1 cells deficient in PCNA ubiquitination, generated through CRISPR/Cas9 gene editing, here, we show that this modification promotes cellular proliferation and suppression of genomic instability under normal growth conditions. Loss of PCNA-ubiquitination results in DNA2-dependent but MRE11-independent nucleolytic degradation of nascent DNA at stalled replication forks. This degradation is linked to defective gap-filling in the wake of the replication fork and incomplete Okazaki fragment maturation, which interferes with efficient PCNA unloading by ATAD5 and subsequent nucleosome deposition by CAF-1. Moreover, concomitant loss of PCNA-ubiquitination and the BRCA pathway results in increased nascent DNA degradation and PARP inhibitor sensitivity. In conclusion, we show that by ensuring efficient Okazaki fragment maturation, PCNA-ubiquitination protects fork integrity and promotes the resistance of BRCA-deficient cells to PARP-inhibitors.

multidisciplinary sciences
A double-ring of human RAD52 remodels replication forks restricting fork reversal

Masayoshi Honda,Mortezaali Razzaghi,Paras Gaur,Eva Malacaria,Giorgia Marozzi,Ludovica Di Biagi,Francesca Antonella Aiello,Emeleeta A. Paintsil,Andrew J. Stanfield,Bailey J. Deppe,Lokesh Gakhar,Nicholas J. Schnicker,M. Ashley Spies,Pietro Pichierri,Maria Spies

DOI: https://doi.org/10.1101/2023.11.14.566657

2024-09-18

Abstract:Human RAD52 is a multifunctional DNA repair protein involved in several cellular events that support genome stability including protection of stalled DNA replication forks from excessive degradation . In its gatekeeper role, RAD52 binds to and stabilizes stalled replication forks during replication stress protecting them from reversal by SMARCAL1 . The structural and molecular mechanism of the RAD52-mediated fork protection remains elusive. Here, using P1 nuclease sensitivity, biochemical and single-molecule analyses we show that RAD52 dynamically remodels replication forks through its strand exchange activity. The presence of the ssDNA binding protein RPA at the fork modulates the kinetics of the strand exchange without impeding the reaction outcome. Mass photometry and single-particle cryo-electron microscopy show that the replication fork promotes a unique nucleoprotein structure containing head-to-head arrangement of two undecameric RAD52 rings with an extended positively charged surface that accommodates all three arms of the replication fork. We propose that the formation and continuity of this surface is important for the strand exchange reaction and for competition with SMARCAL1.

Biochemistry
PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells

Qunsong Tan,Xingzhi Xu

DOI: https://doi.org/10.1016/j.jbc.2024.107312

Abstract:Homologous-recombination deficiency due to breast cancer 1/2 (BRCA1/2) mutations or mimicking BRCA1/2 mutations confer synthetic lethality with poly-(ADP)-ribose polymerase 1/2 inhibitors. The chromatin regulator Pax2 transactivation domain interacting protein (PTIP) promotes stalled replication fork degradation in BRCA1-deficient cells, but the underlying mechanism by which PTIP regulates stalled replication fork stability is unclear. Here, we performed a series of in vitro analyses to dissect the function of UFMylation in regulating fork stabilization in BRCA1-deficient cells. By denaturing co-immunoprecipitation, we first found that replication stress can induce PTIP UFMylation. Interestingly, this post-translational modification promotes end resection and degradation of nascent DNA at stalled replication forks in BRCA1-deficient cells. By cell viability assay, we found that PTIP-depleted and UFL1-depleted BRCA1 knockdown cells are less sensitive to poly-(ADP)-ribose polymerase inhibitors than the siRNA targeting negative control BRCA1-deficient cells. These results identify a new mechanism by which PTIP UFMylation confers chemoresistance in BRCA1-deficient cells.
SMARCAD1-mediated active replication fork stability maintains genome integrity

Calvin Shun Yu Lo,Marvin van Toorn,Vincent Gaggioli,Mariana Paes Dias,Yifan Zhu,Eleni Maria Manolika,Wei Zhao,Marit van der Does,Chirantani Mukherjee,João G. S. C. Souto Gonçalves,Martin E. van Royen,Pim J. French,Jeroen Demmers,Ihor Smal,Hannes Lans,David Wheeler,Jos Jonkers,Arnab Ray Chaudhuri,Jurgen A. Marteijn,Nitika Taneja

DOI: https://doi.org/10.1126/sciadv.abe7804

IF: 13.6

2021-05-07

Science Advances

Abstract:The interplay of SMARCAD1-mediated active fork and BRCA1-mediated stalled fork stability pathways maintains genome integrity.

multidisciplinary sciences
53BP1 and BRCA1 Control Pathway Choice for Stalled Replication Restart

Yixi Xu,Shaokai Ning,Zheng Wei,Ran Xu,Xinlin Xu,Mengtan Xing,Rong Guo,Dongyi Xu

DOI: https://doi.org/10.7554/elife.30523

IF: 7.7

2017-01-01

eLife

Abstract:The cellular pathways that restart stalled replication forks are essential for genome stability and tumor prevention. However, how many of these pathways exist in cells and how these pathways are selectively activated remain unclear. Here, we describe two major fork restart pathways, and demonstrate that their selection is governed by 53BP1 and BRCA1, which are known to control the pathway choice to repair double-strand DNA breaks (DSBs). Specifically, 53BP1 promotes a fork cleavage-free pathway, whereas BRCA1 facilitates a break-induced replication (BIR) pathway coupled with SLX-MUS complex-mediated fork cleavage. The defect in the first pathway, but not DSB repair, in a 53BP1 mutant is largely corrected by disrupting BRCA1, and vice versa. Moreover, PLK1 temporally regulates the switch of these two pathways through enhancing the assembly of the SLX-MUS complex. Our results reveal two distinct fork restart pathways, which are antagonistically controlled by 53BP1 and BRCA1 in a DSB repair-independent manner.
Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability

Suhas S Kharat,Xia Ding,Divya Swaminathan,Akshey Suresh,Manish Singh,Satheesh K Sengodan,Sandra Burkett,Hanna Marks,Chinmayi Pamala,Yafeng He,Stephen D Fox,Eugen C Buehler,Kathrin Muegge,Scott E Martin,Shyam K Sharan

DOI: https://doi.org/10.1126/scisignal.aba8091

2020-08-18

Abstract:Synthetic lethality between poly(ADP-ribose) polymerase (PARP) inhibition and BRCA deficiency is exploited to treat breast and ovarian tumors. However, resistance to PARP inhibitors (PARPis) is common. To identify potential resistance mechanisms, we performed a genome-wide RNAi screen in BRCA2-deficient mouse embryonic stem cells and validation in KB2P1.21 mouse mammary tumor cells. We found that resistance to multiple PARPi emerged with reduced expression of TET2 (ten-eleven translocation), which promotes DNA demethylation by oxidizing 5-methylcytosine (5mC) to 5-hydroxymethycytosine (5hmC) and other products. TET2 knockdown in BRCA2-deficient cells protected stalled replication forks (RFs). Increasing 5hmC abundance induced the degradation of stalled RFs in KB2P1.21 and human cancer cells by recruiting the base excision repair-associated apurinic/apyrimidinic endonuclease APE1, independent of the BRCA2 status. TET2 loss did not affect the recruitment of the repair protein RAD51 to sites of double-strand breaks (DSBs) or the abundance of proteins associated with RF integrity. The loss of TET2, of its product 5hmC, and of APE1 recruitment to stalled RFs promoted resistance to the chemotherapeutic cisplatin. Our findings reveal a previously unknown role for the epigenetic mark 5hmC in maintaining the integrity of stalled RFs and a potential resistance mechanism to PARPi and cisplatin.
The mechanism of checkpoint-dependent DNA replication fork stabilization in human cells

Agostina P. Bertolin,Berta Canal,Mona Yekezare,Jingkun Zeng,Rachael Instrell,Michael Howell,John F.X. Diffley

DOI: https://doi.org/10.1101/2024.11.01.621514

2024-11-03

Abstract:The DNA damage checkpoint is crucial for maintaining genome stability after genotoxic stress; without it, excess DNA replication origins are activated, stalled DNA replication forks cannot restart normally, high levels of DNA damage and single-stranded DNA (ssDNA) accumulate and cells cannot complete S phase. Preventing excess origin firing suppresses all these effects. Here we show that when replication is not restrained by a functional checkpoint, excess DNA synthesis sequesters the processivity factor PCNA and its loader RFC, preventing normal fork restart. Nascent DNA ends unprotected by RFC/PCNA are attacked by the Helicase-Like Transcription Factor (HLTF), causing irreversible replication fork collapse and hyperaccumulation of single-stranded DNA. This explains how the checkpoint stabilizes stalled replication forks and has implications for how origin firing is normally coordinated with fork progression. Loss of HLTF suppresses fork collapse and cell lethality in checkpoint-deficient cells, which has implications for how resistance to anti-checkpoint therapies may arise.

Cell Biology
Isomerization of BRCA1–BARD1 promotes replication fork protection

Manuel Daza-Martin,Katarzyna Starowicz,Mohammed Jamshad,Stephanie Tye,George E. Ronson,Hannah L. MacKay,Anoop Singh Chauhan,Alexandra K. Walker,Helen R. Stone,James F. J. Beesley,Jennifer L. Coles,Alexander J. Garvin,Grant S. Stewart,Thomas J. McCorvie,Xiaodong Zhang,Ruth M. Densham,Joanna R. Morris

DOI: https://doi.org/10.1038/s41586-019-1363-4

IF: 64.8

2019-07-01

Nature

Abstract:The integrity of genomes is constantly threatened by problems encountered by the replication fork. BRCA1, BRCA2 and a subset of Fanconi anaemia proteins protect stalled replication forks from degradation by nucleases, through pathways that involve RAD51. The contribution and regulation of BRCA1 in replication fork protection, and how this role relates to its role in homologous recombination, is unclear. Here we show that BRCA1 in complex with BARD1, and not the canonical BRCA1–PALB2 interaction, is required for fork protection. BRCA1–BARD1 is regulated by a conformational change mediated by the phosphorylation-directed prolyl isomerase PIN1. PIN1 activity enhances BRCA1–BARD1 interaction with RAD51, thereby increasing the presence of RAD51 at stalled replication structures. We identify genetic variants of BRCA1–BARD1 in patients with cancer that exhibit poor protection of nascent strands but retain homologous recombination proficiency, thus defining domains of BRCA1–BARD1 that are required for fork protection and associated with cancer development. Together, these findings reveal a BRCA1-mediated pathway that governs replication fork protection.

multidisciplinary sciences

Supplementary Figure 4 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Supplementary Figure 5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Supplementary Figure 2 from Mre11-Dependent Degradation of Stalled DNA Replication Forks is Prevented by BRCA2 and PARP1

Supplementary Figure Legends 1-5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Supplementary Figure Legends from DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair

A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells

BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage

UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

DNA replication fork stabilization and restart mechanisms revealed by biochemical reconstitution

The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

Replication fork stalling in late S-phase elicits nascent strand degradation by DNA mismatch repair

C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption

Ubiquitinated-PCNA protects replication forks from DNA2-mediated degradation by regulating Okazaki fragment maturation and chromatin assembly

A double-ring of human RAD52 remodels replication forks restricting fork reversal

PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells

SMARCAD1-mediated active replication fork stability maintains genome integrity

53BP1 and BRCA1 Control Pathway Choice for Stalled Replication Restart

Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability

The mechanism of checkpoint-dependent DNA replication fork stabilization in human cells

Isomerization of BRCA1–BARD1 promotes replication fork protection